MicroRNA Signatures in Thyroid Carcinomas
Author Information
Author(s): Juliane Braun, Stefan Hüttelmaier
Primary Institution: Martin Luther University of Halle-Wittenberg
Hypothesis
Deregulated microRNA expression plays a pivotal role in the progression of thyroid carcinomas of follicular origin.
Conclusion
Deregulated microRNA expression is associated with the progression of thyroid carcinomas, providing potential diagnostic and therapeutic targets.
Supporting Evidence
- MicroRNA signatures can distinguish between different types of thyroid carcinomas.
- Upregulation of specific microRNAs is associated with aggressive forms of thyroid cancer.
- MicroRNAs may serve as potential biomarkers for diagnosis and treatment of thyroid cancer.
Takeaway
This study looks at tiny molecules called microRNAs that can help doctors understand and treat thyroid cancer better.
Methodology
The study summarizes findings from various research articles on microRNA expression in thyroid carcinomas.
Limitations
The study highlights the need for more comprehensive analyses to confirm the findings and establish clear diagnostic markers.
Participant Demographics
The study includes data from various thyroid carcinoma types, including FTCs, PTCs, PDTCs, and ATCs.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website